Revatio and Oropharyngeal pain - a phase IV clinical study of FDA data
We study 44,295 people who have side effects when taking Revatio. Oropharyngeal pain is found, especially among people who are female, 60+ old, have been taking the drug for < 1 month, also take Tyvaso and have Cor pulmonale chronic.
The phase IV clinical study analyzes which people take Revatio and have Oropharyngeal pain. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
44,295 people reported to have side effects when taking Revatio.
Among them, 426 people (0.96%) have Oropharyngeal pain.
What is Revatio?
Revatio has active ingredients of sildenafil citrate. It is used in pulmonary hypertension. Currently, eHealthMe is studying from 44,383 Revatio users.
What is Oropharyngeal pain?
Oropharyngeal pain is found to be associated with 2,592 drugs and 1,931 conditions by eHealthMe. Currently, we are studying 104,384 people who have Oropharyngeal pain.
Number of Revatio and Oropharyngeal pain reports submitted per year:
Time on Revatio when people have Oropharyngeal pain *:
Gender of people who have Oropharyngeal pain when taking Revatio*:
Age of people who have Oropharyngeal pain when taking Revatio *:
Common drugs people take besides Revatio *:
Common side effects people have besides Oropharyngeal pain *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Revatio and have Oropharyngeal pain?Check whether Oropharyngeal pain is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Jeong SY, Jeon SJ, Kim YR, Choi SS, Kwak HS, "A Rare Case of Viagra Induced Toxic Encephalopathy", Investigative Magnetic Resonance Imaging, 2016 Sep .
Revatio side effects by duration, gender and age:
- Revatio side effects (44,383 reports)
Oropharyngeal pain treatments and more:
- Oropharyngeal pain (104,384 reports)
Common drugs associated with Oropharyngeal pain:
- Prednisone: 8,785 reports
- Humira: 7,116 reports
- Methotrexate: 7,102 reports
- Enbrel: 6,380 reports
- Aspirin: 3,619 reports
- Xolair: 3,292 reports
- Vitamin d: 3,270 reports
- Cosentyx: 3,200 reports
- Tylenol: 3,109 reports
- Metformin: 2,933 reports
All the drugs that are associated with Oropharyngeal pain:
- Oropharyngeal pain (2,592 drugs)
Common conditions associated with Oropharyngeal pain:
- Rheumatoid arthritis: 11,329 reports
- Asthma: 5,338 reports
- Multiple sclerosis: 4,249 reports
- Crohn's disease: 3,930 reports
- Psoriasis: 3,628 reports
- High blood pressure: 3,545 reports
- High blood cholesterol: 2,907 reports
- Pain: 2,608 reports
All the conditions that are associated with Oropharyngeal pain:
- Oropharyngeal pain (1,931 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on sildenafil citrate (the active ingredients of Revatio) and Revatio (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Mexitil and Dermatitis Medicamentosa - 2 seconds ago
- Nuvaring and Acne - 5 seconds ago
- Tobi Podhaler and Provera drug interaction - 9 seconds ago
- Bupropion Hydrochloride and Bosulif drug interaction - 11 seconds ago
- Fentanyl Citrate and Bimatoprost drug interaction - 12 seconds ago
- Torsemide and Cod Liver Oil drug interaction - 15 seconds ago
- Akineton and Extraneal drug interaction - 21 seconds ago
- Milk Of Magnesia and Meperidine Hydrochloride drug interaction - 21 seconds ago
- Temsirolimus and Temazepam drug interaction - 21 seconds ago
- Cerezyme and Jantoven drug interaction - 47 seconds ago